Paper - WANFANG MED ONLINE

You Position: Home > Paper

肺部磨玻璃样病变的诊治进展

( views:49, downloads:1158 )

Author:: No author available

Journal Title:: Chinese Journal of Tuberculosis and Respiratory Diseases

Issue:: 4

DOI:: 10.3760/cma.j.issn.1001-0939.2015.04.014

Key Word:: No keyword available

Abstract：近年来随着胸部CT的普及,肺部磨玻璃密度影(ground glass opacity,GGO)的检出率明显提高,且部分GGO与早期肺癌,特别是支气管肺泡细胞癌(bronchioloalveolar carcinoma,BAC)相关,故临床医生对GGO的关注度提高.目前,肺癌在全世界癌症死亡原因中占首位,令人遗憾的是临床上很多患者发现时已属晚期,仅15％的患者有手术机会,术后5年生存率只有15％[1].据统计,Ⅳ期肺癌患者5年生存率仅为2％左右,早期发现并手术切除的Ⅰ期肺癌5年生存率为54％～ 73％[2],而以GGO为表现的早期肺癌患者术后5年生存率可达100％[3].因此,正确认识及处理肺部GGO,对肺癌的早期诊断、治疗及预后具有重要意义.

Reference

[1]汪金钱.肺部局限性GGO的影像学诊断方法及外科处理策略[J].2013,(6).
[2]岳光华,曹中良.肺局限性磨玻璃影病变36例临床分析[J].2013,(10).
[3]叶波,冯键,潘旭峰,等.T1a期肺腺癌影像学特征与淋巴结转移相关性分析[J].2013,(10).
[4]Lee HJ,Hur J,Nam JE.Diagnostic accuracy of CT fluoroscopy-guided needle aspiration biopsy of ground-glass opacity pulmonary lesions.[J].2009,192(3).
[5]Ping, Zhan,Haiyan, Xie,Chunhua, Xu,etc.Management strategy of solitary pulmonary nodules.[J].2013,5(6).
[6]Yoshida Y,Kokubu A,Suzuki K,etc.Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.[J].2007,37(12).
[7]Ichinose,J.,Kohno,T.,Fujimori,S.,etc.Invasiveness and malignant potential of pulmonary lesions presenting as pure ground-glass opacities[J].2014,20(5).
[8]Travis WD,Brambilla E,Noguchi M,etc.International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.[J].2011,6(2).
[9]Hartman TE,Sykes AM,Clemens MA,etc.Lung Cancer Screening with CT: Mayo Clinic Experience.[J].2003,226(3).
[10]Awai K,Yamashita Y,Nakaura T,etc.Ground-glass opacities on thin-section helical CT: differentiation between bronchioloalveolar carcinoma and atypical adenomatous hyperplasia.[J].2008,190(5).
[11]Yang,H.,Jheon,S.,Cho,S.,etc.Pathology and prognosis of persistent stable pure ground-glass opacity nodules after surgical resection[J].2013,96(4).
[12]R, Rami-Porta,M, Tsuboi.Sublobar resection for lung cancer.[J].2009,33(2).
[13]Yang PC.Epidermal Growth Factor Receptor Mutation Status in Stage I Lung Adenocarcinoma with Different Image Patterns.[J].2011,6(6).
[14]Christine, Chavez,Shinji, Sasada,Takehiro, Izumo,etc.Image-guided bronchoscopy for histopathologic diagnosis of pure ground glass opacity: a case report.[J].2014,6(6).
[15]Inagaki,T.,Ishikawa,Y.,Okumura,S.,etc.Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth[J].2008,3(11).
[16]Yokoi,K.,Kasai,T.,Nakahara,R.,etc.Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage i non-small cell lung cancer[J].2013,95(6).
[17]Sone S,Maruyama Y,Takashima S,etc.Growth rate of small lung cancers detected on mass CT screening.[J].2000,73(876).
[18]Kang WJ,Lee HJ,Chun EJ.Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.[J].2009,65(2).
[19]Silvestri,G.A.,WangMemoli,J.S.,Nietert,P.J..Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule[J].2012,142(2).
[20]Kobayashi,Y.,Sakao,Y.,Deshpande,G.A.,etc.The association between baseline clinical-radiological characteristics and growth of pulmonary nodules with ground-glass opacity[J].2014,83(1).
[21]Nakamura,S.,Fukui,T.,Taniguchi,T.,etc.Prognostic impact of tumor size eliminating the ground glass opacity component modified clinical t descriptors of the tumor, node, metastasis classification of lung cancer[J].2013,8(12).
[22]Oken MM,Hu P,Winslow SD,etc.Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.[J].2010,102(10).
[23]Kobayashi,Y.,Mitsudomi,T.,Usami,N.,etc.How long should small lung lesions of ground-glass opacity be followed?[J].2013,8(3).
[24]VanSchil,P.E.,Asamura,H.,Rusch,V.W.,etc.Surgical implications of the new IASLC/ ATS/ERS adenocarcinoma classification[J].2012,39(2).
[25]Kodama,H.,Yamakado,K.,Hasegawa,T.,etc.Radiofrequency ablation for ground-glass opacity-dominant lung adenocarcinoma[J].2014,25(3).
[26]Eberhardt R,Anantham D,Ernst A,etc.Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial.[J].2007,176(1).
[27]Masao Nakata,Hideyuki Saeki,Ichiro Takata,etc.Focal Ground-Glass Opacity Detected by Low-Dose Helical CT[J].2002,121(5).
[28]Yamashita,Y.,Korogi,Y.,Hisaoka,M.,etc.Adenocarcinomas with predominant ground-glass opacity: Correlation of morphology and molecular biomarkers[J].2012,264(2).
[29]Choi,S.H.,Chae,E.J.,Kim,J.-E.,etc.Percutaneous CT-guided aspiration and core biopsy of pulmonary nodules smaller than 1 cm: Analysis of outcomes of 305 procedures from a tertiary referral center[J].2013,201(5).
[30]Takehiro, Izumo,Shinji, Sasada,Christine, Chavez,etc.The diagnostic utility of endobronchial ultrasonography with a guide sheath and tomosynthesis images for ground glass opacity pulmonary lesions.[J].2013,5(6).
[31]Lee HY,Lee KS.Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.[J].2011,26(2).
[32]Bo, Ye,Ming, Cheng,Xiao-Xiao, Ge,etc.Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas.[J].2014,12.
[33]Naidich DP,Godoy MC.Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management.[J].2009,253(3).
[34]Herold CJ,Patz EF Jr,MacMahon H,etc.Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.[J].2005,237(2).
[35]Lee,S.W.,Leem,C.-S.,Kim,T.J.,etc.The long-term course of ground-glass opacities detected on thin-section computed tomography[J].2013,107(6).
[36]Haluska FG,Louis DN,Christiani DC,etc.Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.[J].2004,350(21).
[37]Kato H,Shimizu K,Tsuboi M,etc.Percutaneous CT-guided fine needle aspiration for lung cancer smaller than 2 cm and revealed by ground-glass opacity at CT.[J].2006,51(2).
[38]Lee SJ,Ahn MJ,Lee HY,etc.Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years.[J].2010,69(1).
[39]Iguchi, Toshihiro,Hiraki, Takao,Gobara, Hideo,etc.Percutaneous Radiofrequency Ablation of Lung Cancer Presenting as Ground-Glass Opacity[J].2015,38(2).